Herein, we performed a comprehensive and systematic study of KCNN4 using pan-cancer datasets, confirming that its aberrant expression and significant downregulation of methylation levels in cancer tissues compared to non-cancerous tissues. The gene discussed is KCNN4; the disease is cancer.